P12-7 A MSI-H mutational advanced gastric cancer case with Bulky N treated by pembrolizumab as a first-line therapy.

MLA

Kobayashi, K., et al. “P12-7 A MSI-H Mutational Advanced Gastric Cancer Case with Bulky N Treated by Pembrolizumab as a First-Line Therapy.” Annals of Oncology, vol. 35, Oct. 2024, p. S1370. EBSCOhost, https://doi.org/10.1016/j.annonc.2024.07.386.

APA

Kobayashi, K., Takemori, K., Yamasaki, H., Kobayashi, S., Miyoshi, T., Kosaka, T., Inoue, Y., Matsushima, H., Kuba, S., Morita, M., Okada, S., Adachi, T., Hara, T., Imamura, H., Yamashita, M., Matsuguma, K., Soyama, A., Adachi, T., Kanetaka, K., & Eguchi, S. (2024). P12-7 A MSI-H mutational advanced gastric cancer case with Bulky N treated by pembrolizumab as a first-line therapy. Annals of Oncology, 35, S1370. https://doi.org/10.1016/j.annonc.2024.07.386

Chicago

Kobayashi, K., K. Takemori, H. Yamasaki, S. Kobayashi, T. Miyoshi, T. Kosaka, Y. Inoue, et al. 2024. “P12-7 A MSI-H Mutational Advanced Gastric Cancer Case with Bulky N Treated by Pembrolizumab as a First-Line Therapy.” Annals of Oncology 35 (October): S1370. doi:10.1016/j.annonc.2024.07.386.